ArticleGynecologic oncology2017

High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.

Henry D Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.